Prospect News: News for Mylan Laboratories Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with M > Issuers starting with M, CV only > All stories on Mylan Laboratories Inc. > Stories on Mylan Laboratories Inc., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Mylan Laboratories Inc.

8/29/2008	CV	Market Commentary: Mylan, Medtronic trade flat to lower; Ambac gives back some gains; energy names quiet despite storm
10/4/2007	CV	Market Commentary: Intel, Micron recover; AMD moves up; Excel Maritime sets sail higher; Molina Healthcare eagerly anticipated
7/11/2007	CV	Market Commentary: Newmont seen coming tight; Kendle, SonoSite active, CVRD moves higher again
7/10/2007	CV	Market Commentary: Kendle, SonoSite talked cheap; Live Nation questioned; Medtronic, Mylan seen safe in choppy market
5/14/2007	BKCVHY	Mylan plans new bank debt, bonds for purchase of Merck's generics business
5/14/2007	BKCVHY	S&P lowers Mylan
5/14/2007	BKCVHY	Moody's may downgrade Mylan
5/14/2007	CV	Market Commentary: Mylan falls on acquisition; Ford gains on Chrysler deal, buyout hopes; Gold Reserve reserved in gray
3/2/2007	CV	Market Commentary: Mylan, Hospitality Properties climb on debut; Health Management, Superior Energy gain with stocks
3/2/2007	CV	New Issue: Mylan prices upsized $550 million five-year convertibles at rich end, at 1.25%, up 15%
2/21/2007	BKCVHY	Moody's rates Mylan loans Ba1
2/20/2007	CV	Mylan to price $400 million five-year convertibles March 1, talked at 1.25%-1.75%, up 10%-15%
2/20/2007	CV	Market Commentary: XM jumps on merger amid put debate; Charys sneaks into secondary market; Mylan deal gets early nods
2/20/2007	CVHY	Mylan Laboratories files automatic shelf registration
9/21/2006	BKBTCVHY	Moody's revises ratings for nine U.S. pharma companies

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.